Dr. Michael Paul Milligan, MD

Dr. Milligan practices at Michael P Milligan MD Inc in Rancho Mirage, California.

Dr. Milligan's NPI, 1790776045, was assigned on November 3, 2005. Dr. Milligan graduated from Georgetown University School Of Medicine in 1978. Dr. Milligan holds California license G46979.

Dr. Milligan's primary practice is Michael P Milligan MD Inc, at 35200 Bob Hope Dr, Rancho Mirage, CA 92270 in Riverside County. The practice phone is (760) 328-8884.

Dr. Milligan's primary practice is Michael P Milligan MD Inc in Rancho Mirage, California. The medical group on file is Milligan Dermatology. Dmand AI also links Dr. Milligan to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Milligan practices. Vendor and product names are available with a free account.

Dermatology is Dr. Milligan's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Milligan is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Milligan's licenses on file in 2 states: California and North Carolina.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and itchy rashes among the conditions Dr. Milligan treats.

CMS data shows 16,896 Medicare services from Dr. Milligan across 26 procedure codes in 2024, for 1,970 Medicare patients. Medicare paid $554,072 for them. Every service was in an office.

CMS counts 1,970 Medicare patients who saw Dr. Milligan in 2024. The largest group is 75 to 84, with 870 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Milligan's median patient age at 75, with 49% women.

In 2024, Dr. Milligan wrote 3,193 Medicare Part D claims for 1,217 patients. 97% of them were for generic drugs. CMS names the drug for 2,996 of them, across 34 drugs with 11 or more claims each, at $278,820 in total drug cost. In 2023, CMS named 3,262 claims across 37 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 0 out of 100 for Dr. Milligan for performance year 2024, reported individually. Dr. Milligan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 2,359 procedures of removal of skin lesions by Dr. Milligan, more than 98% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 239 general payments to Dr. Milligan from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $1,170.

Dmand AI lists 1 award for Dr. Milligan.

Dr. Milligan graduated from Georgetown University School Of Medicine in 1978. Dr. Milligan is a member of AAD.

Dr. Milligan is in network with 16 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.